Locally Advanced Breast Cancer Clinical Trials in Beijing
2 recruitingBeijing, China
Showing 1–2 of 2 trials
Recruiting
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
Metastatic Breast CancerLocally Advanced Breast Cancer
Hoffmann-La Roche500 enrolled17 locationsNCT07347600
Recruiting
Not Applicable
The Choice of Treatment Methods and Efficacy of LABC
Locally Advanced Breast Cancer
Peking Union Medical College Hospital50 enrolled1 locationNCT06080620